This Oregon Evidence-based Practice Center sponsored event hosts Joy A. Melnikow, M.D., M.P.H., director of the Center for Healthcare Policy and Research and professor of Family and Community Medicine at the University of California, Davis. Dr. Melnikow’s presentation, “Breast Cancer Screening: Cost-effectiveness and Health Benefits Model,” will demonstrate a model developed to project costs and health benefits of breast cancer screening program policies. This event, located in BICC room 124, starts at 10 a.m. this Thursday, … Read More
Posts Tagged ‘breast cancer’
The Department of Defense (DoD) has released RFAs for its highly anticipated Breast and Ovarian Cancer Research Programs. Deadlines vary—find the full program announcements below for more information.
A team of OHSU researchers and physicians, led by SuEllen Pommier, Ph.D., associate research professor in the division of surgical oncology, have recently published findings in the Annals of Surgical Oncology that suggest early mutations in breast cancer stem cells may be causing tumors to develop and recur—even after a patient is treated with chemotherapy and radiation. This discovery was the result of a novel method of working with samples taken directly from surgeries, not … Read More
This fall, the Susan G. Komen for the Cure is offering several funding opportunities for breast cancer researchers at various stages of their careers. Here is a brief snapshot of the available opportunities. Refer to the full announcements for more information. Promise Grants – Supports two or three PIs and an investigative team made up of laboratory, clinical, and public health researchers to conduct several related projects, the results of which will answer critical questions … Read More
The Department of Radiation Medicine invites you to a research seminar on Thursday, July 14 with University of Michigan’s Lori J. Pierce, MD, Vice Provost for Academic & Faculty Affairs; Professor of Radiation Oncology; and Program Leader for Breast Radiotherapy. Dr. Pierce’s talk, “Local-Regional Therapy for BRCA1/2-Associated Breast Cancer,” will be held from 8:30 to 9:30 a.m. in Hatfield Research Center room 14D03.
On Tuesday, June 14, James M. Ford, MD, PhD, associate professor of oncology at Stanford University School of Medicine, will give a presentation on “Targeting DNA Repair for the Treatment and Prevention of Triple-Negative Breast Cancer” as part of the Knight Cancer Institute Seminar Series. The seminar will take place from 4 to 5 p.m. in OHSU main hospital room 8B60. It’s free and open to the public. The Knight Cancer Institute seminar series, co-sponsored … Read More
The Department of Defense (DoD) has released RFAs for its highly anticipated Breast Cancer Research Program. Available opportunities include: Postdoctoral Fellowship Award – Provides $100,000 per year for three years for mentored support of recent doctoral graduates. Era of Hope Scholar Award – Supports exceptionally talented and creative early-career scientists. Maximum funding of $2.5 million with a performance period not to exceed five years. Innovator Award – Provides senior faculty with the opportunity to pursue … Read More
OHSU’s Department of Physiology and Pharmacology and the Knight Cancer Institute are cosponsoring the 28th William K. and Carmella L. Riker Memorial Lecture. Featured speaker will be Angela Hartley Brodie, PhD. She will be discussing “Aromatase Inhibitors and Breast Cancer – Concept to Clinic”. Dr. Brodie is a professor in the Department of Pharmacology and Experimental Therapeutics at the University of Maryland. She is well known for her work in the development of aromatase inhibitors … Read More